New Entries:
- UCB announces regulatory filings for Cimzia® (certolizumab pegol)
- Sanofi New Drug Application for lixisenatide accepted for review by FDA
- ViiV Healthcare announces FDA priority review designation for dolutegravir
- Bristol-Myers Squibb enters a collaboration agreement with Reckitt Benckiser Group plc
- Sanofi delivers solid 2012 results despite patent expirations
- Novo Nordisk increased operating profit by 32% in 2012
- AstraZeneca fourth quarter and full year results 2012
